Free Trial

Horizon Kinetics Medical ETF Rating

$27.63 -0.30 (-1.07%)
Closing price 03:58 PM Eastern
Extended Trading
$27.63 0.00 (0.00%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.70

Holdings in MEDX have an aggregate rating of Moderate Buy based on 438 analyst ratings issued in the past year covering 32 companies (88.5% of the portfolio).

MEDX Aggregate Price Target

$27.63
High Prediction$27.63
Average Prediction$27.63
Low Prediction$27.63

Holdings in MEDX have an aggregate price target of $27.63 and a range of $27.63 to $27.63 covering 32 companies (88.5% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
Moderate Buy
16 Moderate Buy rating(s)
Hold
11 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 32 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
16.67%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$826.84
-3.0%
4.8361 of 5 stars
2.85$1,009.72 22.1%20Analyst Revision
Positive News
9.55%
AbbVie Inc. stock logo
ABBV
AbbVie
$201.16
-0.1%
4.5468 of 5 stars
2.92$211.45 5.1%25Positive News
6.42%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$59.18
0.0%
3.9099 of 5 stars
2.32$57.86 -2.2%19Options Volume
Positive News
6.29%
Amgen Inc. stock logo
AMGN
Amgen
$305.71
-0.4%
4.459 of 5 stars
2.46$314.04 2.7%24Positive News
5.54%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$72.72
-0.5%
2.9417 of 5 stars
3.10$89.75 23.4%10Positive News
4.95%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$161.64
+0.4%
4.5801 of 5 stars
2.56$171.33 6.0%18Positive News
4.83%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$269.21
-4.2%
4.3104 of 5 stars
2.76$312.30 16.0%25Analyst Upgrade
4.72%
Alkermes plc stock logo
ALKS
Alkermes
$33.69
-0.6%
4.6193 of 5 stars
2.69$38.46 14.2%13News Coverage
Positive News
4.03%
Pfizer Inc. stock logo
PFE
Pfizer
$25.19
-1.4%
4.9891 of 5 stars
2.63$31.92 26.7%16Analyst Revision
Positive News
3.71%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$88.06
+0.2%
5 of 5 stars
2.65$117.12 33.0%23
2.81%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$640.14
+0.9%
4.8461 of 5 stars
2.76$973.13 52.0%25Short Interest ↑
Positive News
2.62%
GSK plc stock logo
GSK
GSK
$38.28
-0.8%
3.1831 of 5 stars
2.60$43.25 13.0%10
2.60%
Biogen Inc. stock logo
BIIB
Biogen
$142.43
+2.3%
4.8687 of 5 stars
2.43$213.33 49.8%30Positive News
2.58%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$39.18
-4.2%
3.2918 of 5 stars
2.48$73.11 86.6%21
2.43%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$31.49
-2.4%
4.3257 of 5 stars
2.70$59.44 88.8%20Analyst Forecast
1.32%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$21.91
-5.6%
3.4384 of 5 stars
3.00$50.82 131.9%14Short Interest ↑
Positive News
0.92%
Replimune Group, Inc. stock logo
REPL
Replimune Group
$10.40
-2.7%
3.8074 of 5 stars
3.13$19.43 86.8%8Positive News
0.86%
Haleon plc stock logo
HLN
Haleon
$10.05
+0.0%
2.6635 of 5 stars
2.38$10.95 9.0%8
0.77%
Bicycle Therapeutics plc stock logo
BCYC
Bicycle Therapeutics
$8.73
-1.4%
1.9348 of 5 stars
2.75$29.14 233.8%8
0.77%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$8.31
-4.8%
4.4478 of 5 stars
2.63$37.56 351.9%19Analyst Revision
0.73%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$4.77
-0.8%
4.3866 of 5 stars
3.00$16.50 245.9%2Positive News
0.65%
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$3.65
-5.2%
0.8499 of 5 stars
2.001Upcoming Earnings
Positive News
0.51%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$1.64
-7.3%
1.5177 of 5 stars
2.00$11.00 570.7%1Upcoming Earnings
Positive News
0.51%
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.96
+0.2%
2.836 of 5 stars
2.38$6.67 34.4%8Short Interest ↓
0.49%
Sandoz Group AG stock logo
SDZNY
Sandoz Group
$41.69
-4.2%
1.5484 of 5 stars
2.003Short Interest ↑
Gap Down
0.46%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$81.00
-1.8%
3.6896 of 5 stars
2.77$98.75 21.9%13Positive News
0.25%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$1.27
-2.3%
4.0578 of 5 stars
2.07$6.83 438.1%14
0.19%
Viatris Inc. stock logo
VTRS
Viatris
$8.96
+0.1%
1.8214 of 5 stars
1.75$10.50 17.2%4Short Interest ↑
0.18%
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
$1.57
-1.9%
3.0081 of 5 stars
2.90$9.29 491.6%10
0.09%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.27
-3.1%
2.5162 of 5 stars
2.54$2.46 93.6%13Analyst Forecast
Short Interest ↓
News Coverage
0.05%
Mural Oncology plc stock logo
MURA
Mural Oncology
$1.33
-9.5%
2.5928 of 5 stars
2.60$13.00 877.4%5Analyst Downgrade
News Coverage
Gap Up
High Trading Volume
0.04%
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$3.75
-2.6%
2.8359 of 5 stars
2.25$51.00 1,260.0%8

This page (NASDAQ:MEDX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners